{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 241745, "items": [{"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T06:47:17Z", "timestamp": 1575442037158}, "reference-count": 0, "publisher": "Informa UK Limited", "license": [{"URL": "http://creativecommons.org/licenses/by-nc/3.0/", "start": {"date-parts": [[2014, 2, 1]], "date-time": "2014-02-01T00:00:00Z", "timestamp": 1391212800000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CPAA"], "DOI": "10.2147/cpaa.s35033", "type": "journal-article", "created": {"date-parts": [[2014, 2, 24]], "date-time": "2014-02-24T22:35:29Z", "timestamp": 1393281329000}, "page": "35", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways"], "prefix": "10.2147", "author": [{"given": "Henrik", "family": "Wilms", "sequence": "first", "affiliation": []}, {"given": "Philipp", "family": "Arnold", "sequence": "additional", "affiliation": []}, {"given": "Deb", "family": "Mojumder", "sequence": "additional", "affiliation": []}, {"given": "John", "family": "DeToledo", "sequence": "additional", "affiliation": []}, {"given": "Ralph", "family": "Lucius", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2014, 2]]}, "container-title": ["Clinical Pharmacology: Advances and Applications"], "language": "en", "link": [{"URL": "https://www.dovepress.com/getfile.php?fileID=19118", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 10, 30]], "date-time": "2016-10-30T22:15:19Z", "timestamp": 1477865719000}, "score": 79.74498, "issued": {"date-parts": [[2014, 2]]}, "references-count": 0, "URL": "http://dx.doi.org/10.2147/cpaa.s35033", "ISSN": ["1179-1438"], "issn-type": [{"value": "1179-1438", "type": "electronic"}], "subject": ["Pharmacology (medical)"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T01:10:38Z", "timestamp": 1575508238314}, "reference-count": 0, "publisher": "OAE Publishing Inc.", "content-domain": {"domain": ["oaepublish.com"], "crossmark-restriction": false}, "short-container-title": ["CDR"], "DOI": "10.20517/cdr.2019.57", "type": "journal-article", "created": {"date-parts": [[2019, 9, 4]], "date-time": "2019-09-04T12:27:41Z", "timestamp": 1567600061000}, "update-policy": "http://dx.doi.org/10.20517/oae.crossmark.policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies"], "prefix": "10.20517", "author": [{"given": "Poornima", "family": "Paramasivan", "sequence": "first", "affiliation": []}, {"given": "Ibrahim H.", "family": "Kankia", "sequence": "additional", "affiliation": []}, {"given": "Simon P.", "family": "Langdon", "sequence": "additional", "affiliation": []}, {"given": "Yusuf Y.", "family": "Deeni", "sequence": "additional", "affiliation": []}], "member": "8410", "published-online": {"date-parts": [[2019]]}, "container-title": ["Cancer  Drug Resistance"], "deposited": {"date-parts": [[2019, 9, 4]], "date-time": "2019-09-04T12:27:42Z", "timestamp": 1567600062000}, "score": 38.932777, "issued": {"date-parts": [[2019]]}, "references-count": 0, "URL": "http://dx.doi.org/10.20517/cdr.2019.57"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T11:09:12Z", "timestamp": 1575284952163}, "reference-count": 50, "publisher": "Frontiers Media SA", "license": [{"URL": "https://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2018, 4, 23]], "date-time": "2018-04-23T00:00:00Z", "timestamp": 1524441600000}, "delay-in-days": 0, "content-version": "unspecified"}], "funder": [{"DOI": "10.13039/100000002", "name": "National Institutes of Health", "doi-asserted-by": "publisher", "award": ["AI122142, AI25434, AI062885, ES026782"]}], "content-domain": {"domain": ["frontiersin.org"], "crossmark-restriction": true}, "short-container-title": ["Front. Immunol."], "DOI": "10.3389/fimmu.2018.00854", "type": "journal-article", "created": {"date-parts": [[2018, 4, 23]], "date-time": "2018-04-23T10:30:23Z", "timestamp": 1524479423000}, "update-policy": "http://dx.doi.org/10.3389/crossmark-policy", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Protective Role of Nuclear Factor Erythroid 2-Related Factor 2 Against Respiratory Syncytial Virus and Human Metapneumovirus Infections"], "prefix": "10.3389", "volume": "9", "author": [{"given": "Teodora", "family": "Ivanciuc", "sequence": "first", "affiliation": []}, {"given": "Elena", "family": "Sbrana", "sequence": "additional", "affiliation": []}, {"given": "Antonella", "family": "Casola", "sequence": "additional", "affiliation": []}, {"given": "Roberto P.", "family": "Garofalo", "sequence": "additional", "affiliation": []}], "member": "1965", "published-online": {"date-parts": [[2018, 4, 23]]}, "reference": [{"key": "B1", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1056/NEJMoa0804877", "article-title": "The burden of respiratory syncytial virus infection in young children", "volume": "360", "author": "Hall", "year": "2009", "journal-title": "N Engl J Med"}, {"key": "B2", "doi-asserted-by": "publisher", "first-page": "1440", "DOI": "10.1001/jama.282.15.1440", "article-title": "Bronchiolitis-associated hospitalizations among US children, 1980-1996", "volume": "282", "author": "Shay", "year": "1999", "journal-title": "JAMA"}, {"key": "B3", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1055/s-2007-976489", "article-title": "Respiratory syncytial virus infection in adults", "volume": "28", "author": "Falsey", "year": "2007", "journal-title": "Semin Respir Crit Care Med"}, {"key": "B4", "doi-asserted-by": "publisher", "first-page": "186", "DOI": "10.1089/ars.2011.4307", "article-title": "Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities", "volume": "18", "author": "Garofalo", "year": "2013", "journal-title": "Antioxid Redox Signal"}, {"key": "B5", "doi-asserted-by": "publisher", "first-page": "212", "DOI": "10.1016/S0022-3476(95)70547-3", "article-title": "Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection", "volume": "126", "author": "Wang", "year": "1995", "journal-title": "J Pediatr"}, {"key": "B6", "doi-asserted-by": "publisher", "first-page": "1532", "DOI": "10.1086/515575", "article-title": "Immunopathogenesis of respiratory syncytial virus bronchiolitis", "volume": "195", "author": "Bennett", "year": "2007", "journal-title": "J Infect Dis"}, {"key": "B7", "doi-asserted-by": "publisher", "first-page": "393", "DOI": "10.1086/322788", "article-title": "Macrophage inflammatory protein 1-alpha, and not T-helper type 2 cytokines, is associated with severe forms of bronchiolitis", "volume": "184", "author": "Garofalo", "year": "2001", "journal-title": "J Infect Dis"}, {"key": "B8", "doi-asserted-by": "publisher", "first-page": "428", "DOI": "10.1136/adc.71.5.428", "article-title": "Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection", "volume": "71", "author": "Everard", "year": "1994", "journal-title": "Arch Dis Child"}, {"key": "B9", "doi-asserted-by": "publisher", "first-page": "146", "DOI": "10.1046/j.1440-1754.2001.00618.x", "article-title": "Leucocyte populations in respiratory syncytial virus-induced bronchiolitis", "volume": "37", "author": "Smith", "year": "2001", "journal-title": "J Paediatr Child Health"}, {"key": "B10", "doi-asserted-by": "publisher", "first-page": "1861", "DOI": "10.1086/430008", "article-title": "Respiratory syncytial virus load predicts disease severity in previously healthy infants", "volume": "191", "author": "Devincenzo", "year": "2005", "journal-title": "J Infect Dis"}, {"key": "B11", "doi-asserted-by": "publisher", "first-page": "557", "DOI": "10.1016/S1359-6446(04)03139-3", "article-title": "Catalytic antioxidants: a radical approach to new therapeutics", "volume": "9", "author": "Day", "year": "2004", "journal-title": "Drug Discov Today"}, {"key": "B12", "doi-asserted-by": "publisher", "first-page": "1361", "DOI": "10.1164/rccm.200603-319OC", "article-title": "Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation", "volume": "174", "author": "Castro", "year": "2006", "journal-title": "Am J Respir Crit Care Med"}, {"key": "B13", "doi-asserted-by": "publisher", "first-page": "19715", "DOI": "10.1074/jbc.M101526200", "article-title": "Oxidant tone regulates RANTES gene transcription in airway epithelial cells infected with respiratory syncytial virus: role in viral-induced interferon regulatory factor activation", "volume": "276", "author": "Casola", "year": "2001", "journal-title": "J Biol Chem"}, {"key": "B14", "doi-asserted-by": "publisher", "first-page": "2461", "DOI": "10.1074/jbc.M307251200", "article-title": "Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases", "volume": "279", "author": "Liu", "year": "2004", "journal-title": "J Biol Chem"}, {"key": "B15", "doi-asserted-by": "publisher", "first-page": "348", "DOI": "10.1165/rcmb.2008-0330OC", "article-title": "Respiratory syncytial virus induces oxidative stress by modulating antioxidant enzymes", "volume": "41", "author": "Hosakote", "year": "2009", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "B16", "doi-asserted-by": "publisher", "first-page": "1550", "DOI": "10.1164/rccm.201010-1755OC", "article-title": "Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis", "volume": "183", "author": "Hosakote", "year": "2011", "journal-title": "Am J Respir Crit Care Med"}, {"key": "B17", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1016/j.freeradbiomed.2004.02.074", "article-title": "Nrf2 signaling in coordinated activation of antioxidant gene expression", "volume": "36", "author": "Jaiswal", "year": "2004", "journal-title": "Free Radic Biol Med"}, {"key": "B18", "doi-asserted-by": "publisher", "first-page": "1304", "DOI": "10.1016/j.freeradbiomed.2009.07.035", "article-title": "Nrf2:INrf2 (Keap1) signaling in oxidative stress", "volume": "47", "author": "Kaspar", "year": "2009", "journal-title": "Free Radic Biol Med"}, {"key": "B19", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1164/rccm.200804-535OC", "article-title": "Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease", "volume": "179", "author": "Cho", "year": "2009", "journal-title": "Am J Respir Crit Care Med"}, {"key": "B20", "first-page": "4756", "article-title": "Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus", "volume": "72", "author": "Olszewska-Pazdrak", "year": "1998", "journal-title": "J Virol"}, {"key": "B21", "first-page": "265", "article-title": "Respiratory syncytial virus: I. Concentration and purification of the infectious virus", "volume": "32", "author": "Ueba", "year": "1978", "journal-title": "Acta Med Okayama"}, {"key": "B22", "doi-asserted-by": "publisher", "first-page": "114", "DOI": "10.1016/j.virol.2007.12.024", "article-title": "Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis", "volume": "374", "author": "Bao", "year": "2008", "journal-title": "Virology"}, {"key": "B23", "doi-asserted-by": "publisher", "first-page": "2232", "DOI": "10.1128/JVI.78.5.2232-2241.2004", "article-title": "IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection", "volume": "78", "author": "Haeberle", "year": "2004", "journal-title": "J Virol"}, {"key": "B24", "doi-asserted-by": "publisher", "first-page": "684", "DOI": "10.1165/rcmb.2015-0385OC", "article-title": "Hydrogen sulfide is an antiviral and antiinflammatory endogenous gasotransmitter in the airways. Role in respiratory syncytial virus infection", "volume": "55", "author": "Ivanciuc", "year": "2016", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "B25", "doi-asserted-by": "publisher", "first-page": "502", "DOI": "10.1165/rcmb.2013-0414OC", "article-title": "Alveolar macrophages contribute to the pathogenesis of hMPV infection while protecting against RSV infection", "volume": "51", "author": "Kolli", "year": "2014", "journal-title": "Am J Respir Cell Mol Biol"}, {"key": "B26", "doi-asserted-by": "publisher", "first-page": "5557", "DOI": "10.1128/JVI.00264-15", "article-title": "Role of hydrogen sulfide in paramyxovirus infections", "volume": "89", "author": "Li", "year": "2015", "journal-title": "J Virol"}, {"key": "B27", "doi-asserted-by": "publisher", "first-page": "8560", "DOI": "10.1128/JVI.00699-08", "article-title": "T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection", "volume": "82", "author": "Kolli", "year": "2008", "journal-title": "J Virol"}, {"key": "B28", "doi-asserted-by": "publisher", "first-page": "e78849", "DOI": "10.1371/journal.pone.0078849", "article-title": "Critical role of TLR4 in human metapneumovirus mediated innate immune responses and disease pathogenesis", "volume": "8", "author": "Velayutham", "year": "2013", "journal-title": "PLoS One"}, {"key": "B29", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.3390/pathogens2020383", "article-title": "Monitoring therapeutic treatments against Burkholderia infections using imaging techniques", "volume": "2", "author": "Mott", "year": "2013", "journal-title": "Pathogens"}, {"key": "B30", "doi-asserted-by": "publisher", "first-page": "14992", "DOI": "10.1128/JVI.79.23.14992-14997.2005", "article-title": "Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus", "volume": "79", "author": "Guerrero-Plata", "year": "2005", "journal-title": "J Virol"}, {"key": "B31", "doi-asserted-by": "publisher", "first-page": "11752", "DOI": "10.1128/JVI.05360-11", "article-title": "RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection", "volume": "85", "author": "Brasier", "year": "2011", "journal-title": "J Virol"}, {"key": "B32", "doi-asserted-by": "publisher", "first-page": "6800", "DOI": "10.1128/JVI.76.13.6800-6814.2002", "article-title": "Identification of NF-kB dependent gene networks in respiratory syncytial virus-infected cells", "volume": "76", "author": "Tian", "year": "2002", "journal-title": "J Virol"}, {"key": "B33", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1086/344644", "article-title": "Respiratory syncytial virus-induced activation of NF-kB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways", "volume": "186", "author": "Haeberle", "year": "2002", "journal-title": "J Infect Dis"}, {"key": "B34", "doi-asserted-by": "publisher", "first-page": "1433", "DOI": "10.1164/rccm.2109077", "article-title": "Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappaB activation", "volume": "165", "author": "Haeberle", "year": "2002", "journal-title": "Am J Respir Crit Care Med"}, {"key": "B35", "doi-asserted-by": "publisher", "first-page": "465", "DOI": "10.1089/ars.2012.4944", "article-title": "The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613", "volume": "19", "author": "Hourihan", "year": "2013", "journal-title": "Antioxid Redox Signal"}, {"key": "B36", "doi-asserted-by": "publisher", "first-page": "791", "DOI": "10.1152/physrev.00017.2011", "article-title": "Physiological implications of hydrogen sulfide: a whiff exploration that blossomed", "volume": "92", "author": "Wang", "year": "2012", "journal-title": "Physiol Rev"}, {"key": "B37", "doi-asserted-by": "publisher", "first-page": "3323", "DOI": "10.1128/JVI.02198-08", "article-title": "Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice", "volume": "83", "author": "Darniot", "year": "2009", "journal-title": "J Virol"}, {"key": "B38", "doi-asserted-by": "publisher", "first-page": "10070", "DOI": "10.1128/JVI.01347-13", "article-title": "The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection", "volume": "87", "author": "Stokes", "year": "2013", "journal-title": "J Virol"}, {"key": "B39", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1016/j.freeradbiomed.2015.05.043", "article-title": "Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of NRF2", "volume": "88", "author": "Komaravelli", "year": "2015", "journal-title": "Free Radic Biol Med"}, {"key": "B40", "doi-asserted-by": "publisher", "first-page": "L991", "DOI": "10.1152/ajplung.00192.2012", "article-title": "Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus", "volume": "303", "author": "Hosakote", "year": "2012", "journal-title": "Am J Physiol Lung Cell Mol Physiol"}, {"key": "B41", "doi-asserted-by": "publisher", "first-page": "10025", "DOI": "10.1007/s00253-013-4775-3", "article-title": "PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice", "volume": "97", "author": "Shi", "year": "2013", "journal-title": "Appl Microbiol Biotechnol"}, {"key": "B42", "doi-asserted-by": "publisher", "first-page": "1255", "DOI": "10.1016/j.jaci.2008.01.016", "article-title": "Nrf2 activation by sulforaphane restores the age-related decrease of T(H)1 immunity: role of dendritic cells", "volume": "121", "author": "Kim", "year": "2008", "journal-title": "J Allergy Clin Immunol"}, {"key": "B43", "doi-asserted-by": "publisher", "first-page": "984", "DOI": "10.1172/JCI25790", "article-title": "Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis", "volume": "116", "author": "Thimmulappa", "year": "2006", "journal-title": "J Clin Invest"}, {"key": "B44", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1016/j.virol.2006.05.022", "article-title": "Ikkepsilon regulates viral-induced interferon regulatory factor-3 activation via a redox-sensitive pathway", "volume": "353", "author": "Indukuri", "year": "2006", "journal-title": "Virology"}, {"key": "B45", "doi-asserted-by": "publisher", "first-page": "11624", "DOI": "10.1038/ncomms11624", "article-title": "Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription", "volume": "7", "author": "Kobayashi", "year": "2016", "journal-title": "Nat Commun"}, {"key": "B46", "doi-asserted-by": "publisher", "first-page": "634", "DOI": "10.3201/eid0906.030017", "article-title": "Human metapneumovirus infections in hospitalized children", "volume": "9", "author": "Boivin", "year": "2003", "journal-title": "Emerg Infect Dis"}, {"key": "B47", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1097/00001432-200306000-00012", "article-title": "Human metapneumovirus: a newly emerging respiratory pathogen", "volume": "16", "author": "Kahn", "year": "2003", "journal-title": "Curr Opin Infect Dis"}, {"key": "B48", "doi-asserted-by": "publisher", "first-page": "633", "DOI": "10.1056/NEJMoa1204630", "article-title": "Burden of human metapneumovirus infection in young children", "volume": "368", "author": "Edwards", "year": "2013", "journal-title": "N Engl J Med"}, {"key": "B49", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1016/j.siny.2010.04.001", "article-title": "Maturation of the antioxidant system and the effects on preterm birth", "volume": "15", "author": "Davis", "year": "2010", "journal-title": "Semin Fetal Neonatal Med"}, {"key": "B50", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1203/00006450-198201001-00013", "article-title": "The development of cystathionase activity during the first year of life", "volume": "16", "author": "Zlotkin", "year": "1982", "journal-title": "Pediatr Res"}], "container-title": ["Frontiers in Immunology"], "link": [{"URL": "http://journal.frontiersin.org/article/10.3389/fimmu.2018.00854/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 4, 23]], "date-time": "2018-04-23T10:30:26Z", "timestamp": 1524479426000}, "score": 33.819565, "issued": {"date-parts": [[2018, 4, 23]]}, "references-count": 50, "alternative-id": ["10.3389/fimmu.2018.00854"], "URL": "http://dx.doi.org/10.3389/fimmu.2018.00854", "relation": {"cites": []}, "ISSN": ["1664-3224"], "issn-type": [{"value": "1664-3224", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T09:16:17Z", "timestamp": 1574414177075}, "publisher-location": "Berlin, Heidelberg", "reference-count": 27, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642675560", "type": "print"}, {"value": "9783642675546", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1980]]}, "DOI": "10.1007/978-3-642-67554-6_38", "type": "book-chapter", "created": {"date-parts": [[2011, 11, 2]], "date-time": "2011-11-02T10:19:30Z", "timestamp": 1320229170000}, "page": "207-212", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Viral-Induced Immunological Incompetence as an Etiologic Factor in Multiple Sclerosis"], "prefix": "10.1007", "author": [{"given": "L. P.", "family": "Weiner", "sequence": "first", "affiliation": []}, {"given": "S. A.", "family": "Stohlman", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "38_CR1", "first-page": "3", "volume": "10", "author": "AC Allison", "year": "1974", "unstructured": "Allison AC (1974) Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev 10:3\u201355", "journal-title": "Transplant Rev"}, {"key": "38_CR2", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1016/S0022-3476(77)80700-2", "volume": "90", "author": "JA Bardelas", "year": "1977", "unstructured": "Bardelas JA, Winklestein JA, Seto DSY (1977) Fatal ECHO 24 infection in a patient with hypogammaglobulinemia: relationship to dermato-like syndrome. J Pediatr 90:396\u2013399", "journal-title": "J Pediatr"}, {"key": "38_CR3", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1016/0008-8749(73)90014-2", "volume": "6", "author": "CE Buckley", "year": "1973", "unstructured": "Buckley CE, Zitt MJ, Cate TR (1973) Two categories of lymphocyte unresponsiveness to phytohemagglutinin. Cell Immunol 6:140\u2013148", "journal-title": "Cell Immunol"}, {"key": "38_CR4", "first-page": "1", "volume": "14", "author": "PB Dent", "year": "1972", "unstructured": "Dent PB (1972) Immunodepression by oncogenic viruses. Prog Med Virol 14:1\u201335", "journal-title": "Prog Med Virol"}, {"key": "38_CR5", "author": "H Friedman", "first-page": "17", "year": "1975", "unstructured": "Friedman H (1975) Immunosuppression by murine leukemia viruses. In: Koprowski C, Koprowski H (eds) Viruses and immunity. Academic Press, New York, pp 17\u201348", "volume-title": "Viruses and immunity"}, {"key": "38_CR6", "first-page": "212", "volume": "10", "author": "CA Kauffman", "year": "1974", "unstructured": "Kauffman CA, Phair JP, Linnemann CC, Schiff GM (1974) Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response and T lymphocyte numbers. Infect Immun 10:212\u2013215", "journal-title": "Infect Immun"}, {"key": "38_CR7", "first-page": "1562", "volume": "113", "author": "ES Kleinerman", "year": "1974", "unstructured": "Kleinerman ES, Snyderman R, Daniels CA (1974) Depression of human monocyte Chemotaxis by herpes simplex and influenza viruses. J Immunol 113:1562\u20131567", "journal-title": "J Immunol"}, {"key": "38_CR8", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1016/0042-6822(64)90188-6", "volume": "24", "author": "BWJ Mahy", "year": "1964", "unstructured": "Mahy BWJ (1964) Action of Riley\u2019s plasma enzyme-elevating virus in mice. Virology 24:481\u2013483", "journal-title": "Virology"}, {"key": "38_CR9", "first-page": "1974", "volume": "113", "author": "HF McFarland", "year": "1974", "unstructured": "McFarland HF (1974) The effect of measles in virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity. J Immunol 113:1974\u20131983", "journal-title": "J Immunol"}, {"key": "38_CR10", "first-page": "1", "volume": "18", "author": "CA Mims", "year": "1974", "unstructured": "Mims CA (1974) Factors in the mechanism of persistence of viral infections. Prog Med Virol 18:1\u201314", "journal-title": "Prog Med Virol"}, {"key": "38_CR11", "first-page": "657", "volume": "111", "author": "RF Mortensen", "year": "1973", "unstructured": "Mortensen RF, Ceglowski WS, Friedman H (1973) In vitro assessment of cellular immunity to Rauscher leukemia virus. J Immunol 111:657\u2013660", "journal-title": "J Immunol"}, {"key": "38_CR12", "doi-asserted-by": "publisher", "first-page": "800", "DOI": "10.1093/infdis/135.5.800", "volume": "135", "author": "O Narayan", "year": "1977", "unstructured": "Narayan O, Griffin DE, Silverstein AM (1977) Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis 135:800\u2013806", "journal-title": "J Infect Dis"}, {"key": "38_CR13", "doi-asserted-by": "publisher", "first-page": "525", "DOI": "10.1146/annurev.mi.24.100170.002521", "volume": "24", "author": "AL Notkins", "year": "1970", "unstructured": "Notkins AL, Mergenhagen SE, Howard RJ (1970) Effect of virus infections on the function of the immune system. Annu Rev Microbiol 24:525\u2013538", "journal-title": "Annu Rev Microbiol"}, {"key": "38_CR14", "first-page": "370", "volume": "112", "author": "MBA Oldstone", "year": "1974", "unstructured": "Oldstone MBA, Tishon A, Chiller JM (1974) Chronic virus infection and immune responsiveness. II. Lactic dehydrogenase virus infection and immune response to non-viral antigens. J Immunol 112:370\u2013375", "journal-title": "J Immunol"}, {"key": "38_CR15", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1084/jem.128.1.47", "volume": "128", "author": "GB Olson", "year": "1968", "unstructured": "Olson GB, Dent PB, Rawls WE, South MA, Montgomery JR, Melnick JL, Good RA (1968) Abnormalities of in vitro lymphocyte responses during rubella virus infections. J Exp Med 128:47\u201368", "journal-title": "J Exp Med"}, {"key": "38_CR16", "first-page": "197", "volume": "21", "author": "AR Page", "year": "1963", "unstructured": "Page AR, Hansen AE, Good RA (1963) Occurrence of leukemia and lymphoma in patients with agammaglobulinemia. Blood 21:197\u2013206", "journal-title": "Blood"}, {"key": "38_CR17", "doi-asserted-by": "publisher", "first-page": "1297", "DOI": "10.1055/s-0028-1135624", "volume": "34", "author": "C Pirquet von", "year": "1908", "unstructured": "Pirquet C von (1908) Das Verhalten der kutanen Tuberkulinreaktion w\u00e4hrend der Masern. Dtsch Med Wochenschr 34:1297\u20131300", "journal-title": "Dtsch Med Wochenschr"}, {"key": "38_CR18", "first-page": "583", "volume": "40", "author": "HG Purchase", "year": "1968", "unstructured": "Purchase HG, Chubb RC, Biggs PM (1968) Effect of lymphoid leukosis and Marek\u2019s disease on the immunological responsiveness of the chicken. J Natl Cancer Inst 40:583\u2013592", "journal-title": "J Natl Cancer Inst"}, {"key": "38_CR19", "first-page": "1", "volume": "13", "author": "KEK Rowson", "year": "1975", "unstructured": "Rowson KEK, Mahy BWJ (1975) Lactic dehydrogenase virus. Virol Monogr 13:1\u2013121", "journal-title": "Virol Monogr"}, {"key": "38_CR20", "first-page": "1411", "volume": "111", "author": "FJCJ Soontiens", "year": "1973", "unstructured": "Soontiens FJCJ, Veen J van der (1973) Evidence for a macrophage mediated effect of polio virus on the lymphocyte response to phytohemagglutinin. J Immunol 111:1411\u20131419", "journal-title": "J Immunol"}, {"key": "38_CR21", "first-page": "877", "volume": "108", "author": "MJ Snodgrass", "year": "1972", "unstructured": "Snodgrass MJ, Lowry DS, Hanna MG (1972) Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J Immunol 108:877\u2013892", "journal-title": "J Immunol"}, {"key": "38_CR22", "first-page": "1193", "volume": "47", "author": "CM Steel", "year": "1971", "unstructured": "Steel CM, Edmund E (1971) Human lymphoblastoid cell lines. I. Culture methods and examination for Epstein-Barr virus. J Natl Cancer Inst 47:1193\u20131201", "journal-title": "J Natl Cancer Inst"}, {"key": "38_CR23", "first-page": "255", "volume": "22", "author": "JL Virelizier", "year": "1975", "unstructured": "Virelizier JL (1975) Mechanisms of immunodepression induced by viruses: possible role of infected macrophages. Biomedicine 22:255\u2013261", "journal-title": "Biomedicine"}, {"key": "38_CR24", "doi-asserted-by": "publisher", "first-page": "579", "DOI": "10.1146/annurev.mi.30.100176.003051", "volume": "30", "author": "RG White", "year": "1976", "unstructured": "White RG (1976) The adjuvant effect of microbial products on the immune response. Annu Rev Microbiol 30:579\u2013600", "journal-title": "Annu Rev Microbiol"}, {"key": "38_CR25", "doi-asserted-by": "publisher", "first-page": "1485", "DOI": "10.1056/NEJM197706302962601", "volume": "296", "author": "CM Wilfert", "year": "1977", "unstructured": "Wilfert CM, Buckley RH, Mohanakumar T, Griffith JF, Katz SL, Whisnant JK, Eggleston PA, Moore M, Treadwell E, Oxman MN, Rosen FS (1977) Persistent and fatal central nervous system echo virus infections in patients with agammaglobulinemia. N Engl J Med 296:1485\u20131489", "journal-title": "N Engl J Med"}, {"key": "38_CR26", "doi-asserted-by": "crossref", "first-page": "652", "DOI": "10.3181/00379727-130-33628", "volume": "130", "author": "FTC Willems", "year": "1969", "unstructured": "Willems FTC, Melnick JL, Rawls WE (1969) Viral inhibition of the phytohemagglutinin response of human lymphocytes and application to viral hepatitis. Proc Soc Exp Biol Med 130:652\u2013661", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "38_CR27", "first-page": "120", "volume": "19", "author": "JF Woodruff", "year": "1975", "unstructured": "Woodruff JF, Woodruff JJ (1975) T lymphocyte interaction with viruses and virus infected tissues. Prog Med Virol 19:120\u2013160", "journal-title": "Prog Med Virol"}], "container-title": ["Progress in Multiple Sclerosis Research"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-67554-6_38", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 5]], "date-time": "2019-11-05T01:14:59Z", "timestamp": 1572916499000}, "score": 31.854372, "issued": {"date-parts": [[1980]]}, "ISBN": ["9783642675560", "9783642675546"], "references-count": 27, "URL": "http://dx.doi.org/10.1007/978-3-642-67554-6_38", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T13:50:46Z", "timestamp": 1574689846715}, "reference-count": 6, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T00:00:00Z", "timestamp": 1430438400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "msard-journal.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.1016/j.msard.2015.03.008", "type": "journal-article", "created": {"date-parts": [[2015, 4, 14]], "date-time": "2015-04-14T05:00:39Z", "timestamp": 1428987639000}, "page": "284-286", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?"], "prefix": "10.1016", "volume": "4", "author": [{"given": "Eavan Mc", "family": "Govern", "sequence": "first", "affiliation": []}, {"given": "Eoin P", "family": "Judge", "sequence": "additional", "affiliation": []}, {"given": "Eoin", "family": "Kavanagh", "sequence": "additional", "affiliation": []}, {"given": "Sean", "family": "Gaine", "sequence": "additional", "affiliation": []}, {"given": "Timothy", "family": "Lynch", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034815000383?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034815000383?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 23]], "date-time": "2018-09-23T14:27:39Z", "timestamp": 1537712859000}, "score": 30.883213, "issued": {"date-parts": [[2015, 5]]}, "references-count": 6, "journal-issue": {"published-print": {"date-parts": [[2015, 5]]}, "issue": "3"}, "alternative-id": ["S2211034815000383"], "URL": "http://dx.doi.org/10.1016/j.msard.2015.03.008", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Interferon beta related pulmonary arterial hypertension; an emerging worrying entity?", "name": "articletitle", "label": "Article Title"}, {"value": "Multiple Sclerosis and Related Disorders", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.msard.2015.03.008", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:58:18Z", "timestamp": 1574445498717}, "reference-count": 28, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 4, 1]], "date-time": "2012-04-01T00:00:00Z", "timestamp": 1333238400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2012, 4]]}, "DOI": "10.1016/j.msard.2011.12.002", "type": "journal-article", "created": {"date-parts": [[2012, 1, 18]], "date-time": "2012-01-18T23:24:05Z", "timestamp": 1326929045000}, "page": "61-63", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Epstein\u2013Barr virus in the multiple sclerosis brain \u2013 An evasive culprit"], "prefix": "10.1016", "volume": "1", "author": [{"given": "Michael P.", "family": "Pender", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034811000381?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034811000381?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T17:15:57Z", "timestamp": 1561223757000}, "score": 28.349884, "issued": {"date-parts": [[2012, 4]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2012, 4]]}, "issue": "2"}, "alternative-id": ["S2211034811000381"], "URL": "http://dx.doi.org/10.1016/j.msard.2011.12.002", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:33:12Z", "timestamp": 1574742792956}, "reference-count": 57, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "msard-journal.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2016, 1]]}, "DOI": "10.1016/j.msard.2015.11.005", "type": "journal-article", "created": {"date-parts": [[2015, 11, 11]], "date-time": "2015-11-11T13:00:50Z", "timestamp": 1447246850000}, "page": "77-80", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Important role of mast cells in multiple sclerosis"], "prefix": "10.1016", "volume": "5", "author": [{"given": "P.", "family": "Conti", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Kempuraj", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034815300201?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034815300201?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 17]], "date-time": "2018-09-17T20:24:33Z", "timestamp": 1537215873000}, "score": 28.349884, "issued": {"date-parts": [[2016, 1]]}, "references-count": 57, "alternative-id": ["S2211034815300201"], "URL": "http://dx.doi.org/10.1016/j.msard.2015.11.005", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Important role of mast cells in multiple sclerosis", "name": "articletitle", "label": "Article Title"}, {"value": "Multiple Sclerosis and Related Disorders", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.msard.2015.11.005", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier B.V. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T09:14:00Z", "timestamp": 1574154840275}, "reference-count": 0, "publisher": "SAGE Publications", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1999, 6, 1]]}, "DOI": "10.1191/135245899678846474", "type": "journal-article", "created": {"date-parts": [[2003, 3, 8]], "date-time": "2003-03-08T06:12:50Z", "timestamp": 1047103970000}, "page": "389-394", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis"], "prefix": "10.1177", "volume": "5", "author": [{"given": "A.", "family": "Micera", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Lambiase", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Rama", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Aloe", "sequence": "additional", "affiliation": []}], "member": "179", "container-title": ["Multiple Sclerosis"], "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1191/135245899678846474", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 11, 3]], "date-time": "2017-11-03T11:36:11Z", "timestamp": 1509708971000}, "score": 28.011677, "issued": {"date-parts": [[1999, 6, 1]]}, "references-count": 0, "journal-issue": {"issue": "6"}, "alternative-id": ["1352-4585(19990601)5:6L.389;1-"], "URL": "http://dx.doi.org/10.1191/135245899678846474", "ISSN": ["1477-0970", "1352-4585"], "issn-type": [{"value": "1352-4585", "type": "print"}, {"value": "1477-0970", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:18:55Z", "timestamp": 1574475535569}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurology"], "published-print": {"date-parts": [[1997, 4, 1]]}, "DOI": "10.1212/wnl.48.4.826", "type": "journal-article", "created": {"date-parts": [[2012, 5, 13]], "date-time": "2012-05-13T13:28:07Z", "timestamp": 1336915687000}, "page": "826-831", "source": "Crossref", "is-referenced-by-count": 6, "title": ["T-cell tumor necrosis factor-\u00a0 receptor binding in patients with multiple sclerosis"], "prefix": "10.1212", "volume": "48", "author": [{"given": "P.", "family": "Bongioanni", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Meucci", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Neurology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T17:15:19Z", "timestamp": 1518196519000}, "score": 27.845325, "issued": {"date-parts": [[1997, 4, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 4, 1]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1212/wnl.48.4.826", "ISSN": ["0028-3878", "1526-632X"], "issn-type": [{"value": "0028-3878", "type": "print"}, {"value": "1526-632X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T02:35:47Z", "timestamp": 1574562947983}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1016/j.msard.2014.09.172", "type": "journal-article", "created": {"date-parts": [[2014, 11, 21]], "date-time": "2014-11-21T18:31:16Z", "timestamp": 1416594676000}, "page": "747", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Investigation of Oncostatin M protein expression in Iranian relapsing remitting multiple sclerosis patients"], "prefix": "10.1016", "volume": "3", "author": [{"given": "P.", "family": "Alikhani", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Alsahebfosoul", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Shajarian", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034814002764?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034814002764?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T14:54:46Z", "timestamp": 1538060086000}, "score": 27.745657, "issued": {"date-parts": [[2014, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 11]]}, "issue": "6"}, "alternative-id": ["S2211034814002764"], "URL": "http://dx.doi.org/10.1016/j.msard.2014.09.172", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T22:21:01Z", "timestamp": 1576534861179}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 11, 1]], "date-time": "2018-11-01T00:00:00Z", "timestamp": 1541030400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2018, 11]]}, "DOI": "10.1016/j.msard.2018.10.050", "type": "journal-article", "created": {"date-parts": [[2018, 12, 17]], "date-time": "2018-12-17T16:36:40Z", "timestamp": 1545064600000}, "page": "244-245", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Multiple Sclerosis Burden in Eastern Mediterranean Region from 1990 to 2016"], "prefix": "10.1016", "volume": "26", "author": [{"given": "S.", "family": "Eskandarieh", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Heydarpour", "sequence": "additional", "affiliation": []}, {"given": "M.A.", "family": "Sahraian", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034818304176?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034818304176?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 12, 16]], "date-time": "2019-12-16T13:59:20Z", "timestamp": 1576504760000}, "score": 27.745657, "issued": {"date-parts": [[2018, 11]]}, "references-count": 0, "alternative-id": ["S2211034818304176"], "URL": "http://dx.doi.org/10.1016/j.msard.2018.10.050", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}], "subject": ["Neurology", "Clinical Neurology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:45:13Z", "timestamp": 1574311513576}, "reference-count": 0, "publisher": "Society for Neuroscience", "issue": "29", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Neuroscience"], "published-print": {"date-parts": [[2007, 7, 18]]}, "DOI": "10.1523/jneurosci.0823-07.2007", "type": "journal-article", "created": {"date-parts": [[2007, 7, 18]], "date-time": "2007-07-18T17:28:28Z", "timestamp": 1184779708000}, "page": "7777-7785", "source": "Crossref", "is-referenced-by-count": 70, "title": ["Mitochondrial Superoxide Production and Nuclear Factor Erythroid 2-Related Factor 2 Activation in p75 Neurotrophin Receptor-Induced Motor Neuron Apoptosis"], "prefix": "10.1523", "volume": "27", "author": [{"given": "M.", "family": "Pehar", "sequence": "first", "affiliation": []}, {"given": "M. R.", "family": "Vargas", "sequence": "additional", "affiliation": []}, {"given": "K. M.", "family": "Robinson", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Cassina", "sequence": "additional", "affiliation": []}, {"given": "P. J.", "family": "Diaz-Amarilla", "sequence": "additional", "affiliation": []}, {"given": "T. M.", "family": "Hagen", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Radi", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Barbeito", "sequence": "additional", "affiliation": []}, {"given": "J. S.", "family": "Beckman", "sequence": "additional", "affiliation": []}], "member": "393", "container-title": ["Journal of Neuroscience"], "language": "en", "deposited": {"date-parts": [[2011, 8, 2]], "date-time": "2011-08-02T23:04:24Z", "timestamp": 1312326264000}, "score": 27.702827, "issued": {"date-parts": [[2007, 7, 18]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 7, 18]]}, "issue": "29"}, "URL": "http://dx.doi.org/10.1523/jneurosci.0823-07.2007", "ISSN": ["0270-6474", "1529-2401"], "issn-type": [{"value": "0270-6474", "type": "print"}, {"value": "1529-2401", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T02:18:25Z", "timestamp": 1574475505645}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "7", "content-domain": {"domain": ["neurology.org"], "crossmark-restriction": true}, "short-container-title": ["Neurology"], "published-print": {"date-parts": [[1993, 7, 1]]}, "DOI": "10.1212/wnl.43.7.1311", "type": "journal-article", "created": {"date-parts": [[2012, 5, 13]], "date-time": "2012-05-13T13:08:33Z", "timestamp": 1336914513000}, "page": "1311-1311", "update-policy": "http://dx.doi.org/10.1212/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 66, "title": ["Psychological stress as risk factor for exacerbations in multiple sclerosis"], "prefix": "10.1212", "volume": "43", "author": [{"given": "P.", "family": "Nisipeanu", "sequence": "first", "affiliation": []}, {"given": "A. D.", "family": "Korczyn", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Neurology"], "language": "en", "deposited": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T20:16:54Z", "timestamp": 1518207414000}, "score": 27.580517, "issued": {"date-parts": [[1993, 7, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 7, 1]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1212/wnl.43.7.1311", "ISSN": ["0028-3878", "1526-632X"], "issn-type": [{"value": "0028-3878", "type": "print"}, {"value": "1526-632X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:04:51Z", "timestamp": 1574319891028}, "reference-count": 102, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 2920, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1111/j.1742-1241.2007.01561..x", "type": "journal-article", "created": {"date-parts": [[2007, 9, 7]], "date-time": "2007-09-07T11:32:34Z", "timestamp": 1189164754000}, "page": "1922-1930", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Emerging oral therapies for multiple sclerosis"], "prefix": "10.1111", "volume": "61", "author": [{"given": "B. A.", "family": "Cohen", "sequence": "first", "affiliation": []}, {"given": "P.", "family": "Rieckmann", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 9, 3]]}, "reference": [{"key": "10.1111/j.1742-1241.2007.01561..x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1097/01.wco.0000227035.93199.e0", "article-title": "Emerging therapeutic targets in multiple sclerosis", "volume": "19", "author": "Fontoura", "year": "2006", "journal-title": "Curr Opin Neurol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "259", "DOI": "10.1111/j.1750-3639.1996.tb00854.x", "article-title": "Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis", "volume": "6", "author": "Lucchinetti", "year": "1996", "journal-title": "Brain Pathol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "308", "DOI": "10.1002/ana.20182", "article-title": "Evidence for pathogenic heterogeneity in multiple sclerosis", "volume": "56", "author": "Lucchinetti", "year": "2004", "journal-title": "Ann Neurol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "483", "DOI": "10.2165/00023210-200721060-00005", "article-title": "Oral disease-modifying treatments for multiple sclerosis: the story so far", "volume": "21", "author": "Kieseier", "year": "2007", "journal-title": "CNS Drugs"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB5|cit5", "unstructured": "Avonex\u00ae Summary of Product Characteristics http://emc.medicines.org.uk"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB6|cit6", "unstructured": "Betaferon\u00ae Summary of Product Characteristics http://emc.medicines.org.uk"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB7|cit7", "unstructured": "Rebif\u00ae Summary of Product Characteristics http://emc.medicines.org.uk"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB8|cit8", "unstructured": "Copaxone\u00ae Summary of Product Characteristics http://emc.medicines.org.uk"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB9|cit9", "unstructured": "Tysabri\u00ae Summary of Product Characteristics http://emc.medicines.org.uk"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1097/01376517-200606000-00005", "article-title": "Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis", "volume": "38", "author": "Cox", "year": "2006", "journal-title": "J Neurosci Nurs"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1191/1352458505ms1146oa", "article-title": "Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications", "volume": "11", "author": "Mohr", "year": "2005", "journal-title": "Mult Scler"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1207/S15324796ABM2302_7", "article-title": "Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject", "volume": "23", "author": "Mohr", "year": "2001", "journal-title": "Ann Behav Med"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1056/NEJM198208053070607", "article-title": "Intramuscular or intralipomatous injections?", "volume": "307", "author": "Cockshott", "year": "1982", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1496", "DOI": "10.1212/01.WNL.0000034080.43681.DA", "article-title": "Randomized, comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE trial", "volume": "59", "author": "Panitch", "year": "2002", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "306", "DOI": "10.1191/1352458505ms1173oa", "article-title": "Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis", "volume": "11", "author": "Rio", "year": "2005", "journal-title": "Mult Scler"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB16|cit16", "first-page": "366", "article-title": "Recurrent injection site reactions from interferon beta 1-b", "volume": "5", "author": "Samuel", "year": "2006", "journal-title": "J Drugs Dermatol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1111/j.1600-0404.2005.00568.x", "article-title": "Patient satisfaction with an injection device for multiple sclerosis treatment", "volume": "113", "author": "Cramer", "year": "2006", "journal-title": "Acta Neurol Scand"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "551", "DOI": "10.1212/01.WNL.0000078885.05053.7D", "article-title": "Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS", "volume": "61", "author": "Tremlett", "year": "2003", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1007/s00415-006-0281-1", "article-title": "Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis", "volume": "254", "author": "Limmroth", "year": "2007", "journal-title": "J Neurol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB20|cit20", "volume": "352", "first-page": "1498", "year": "1998", "article-title": "Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(98)03334-0", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB21|cit21", "volume": "45", "first-page": "1277", "year": "1995", "article-title": "Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group", "journal-title": "Neurology", "DOI": "10.1212/WNL.45.7.1277", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1191/1352458505ms1197oa", "article-title": "A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis", "volume": "11", "author": "Mikol", "year": "2005", "journal-title": "Mult Scler"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "1128", "DOI": "10.1016/j.clinthera.2007.06.002", "article-title": "Immunogenicity and tolerability of an investigational formulation of interferon beta-1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically-controlled, Phase IIIb study in adults with multiple sclerosis", "volume": "29", "author": "Giovannoni", "year": "2007", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB24|cit24", "first-page": "1563", "article-title": "Consequences of intermittent treatment for hypertension: the case for medication compliance and persistence", "volume": "4", "author": "Cramer", "year": "1998", "journal-title": "Am J Manag Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB25|cit25", "year": "2002", "volume-title": "The World Health Report 2002: Reducing Risks, Promoting Healthy Life"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1891/0739-6686.18.1.48", "article-title": "Adherence in chronic disease", "volume": "18", "author": "Dunbar-Jacob", "year": "2000", "journal-title": "Annu Rev Nurs Res"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB27|cit27", "first-page": "CD000011", "article-title": "Interventions to enhance medication adherence", "volume": "4", "author": "Haynes", "year": "2005", "journal-title": "Cochrane Database Syst Rev"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1097/01.mlr.0000114908.90348.f9", "article-title": "Variations in patients\u2019 adherence to medical recommendations: a quantitative review of 50\u2003years of research", "volume": "42", "author": "DiMatteo", "year": "2004", "journal-title": "Med Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB29|cit29", "author": "World Health Organization", "year": "2003", "volume-title": "Adherence to Long-term Therapies: Evidence for Action"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB30|cit30", "author": "Sackett", "first-page": "11", "year": "1979", "volume-title": "Compliance in Health Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1046/j.1440-1754.2003.00081.x", "article-title": "Sticky issue of adherence", "volume": "39", "author": "Sawyer", "year": "2003", "journal-title": "J Paediatr Child Health"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB32|cit32", "author": "Cluss", "first-page": "403", "year": "1985", "volume-title": "Measurement Strategies in Health Psychology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1086/322698", "article-title": "Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice", "volume": "33", "author": "Stone", "year": "2001", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1016/S0167-5273(00)00374-0", "article-title": "Reasons for adherence with antihypertensive medication", "volume": "76", "author": "Svensson", "year": "2000", "journal-title": "Int J Cardiol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "1977", "DOI": "10.1001/jama.279.24.1977", "article-title": "Public health implications of antiretroviral therapy and HIV drug resistance", "volume": "279", "author": "Wainberg", "year": "1998", "journal-title": "JAMA"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1046/j.1524-4733.2003.65269.x", "article-title": "Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes", "volume": "6", "author": "Cramer", "year": "2003", "journal-title": "Value Health"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "2880", "DOI": "10.1001/jama.288.22.2880", "article-title": "Helping patients follow prescribed treatment: clinical applications", "volume": "288", "author": "Haynes", "year": "2002", "journal-title": "JAMA"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1001/archneur.1997.00550170015009", "article-title": "Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis", "volume": "54", "author": "Mohr", "year": "1997", "journal-title": "Arch Neurol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1177/135245859600200502", "article-title": "et al Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment", "volume": "2", "author": "Mohr", "year": "1996", "journal-title": "Mult Scler"}, {"issue": "Su", "key": "10.1111/j.1742-1241.2007.01561..x-BIB40|cit40", "first-page": "32", "article-title": "Adherence to disease-modifying therapy for multiple sclerosis", "author": "Cohen", "year": "2006", "journal-title": "Int J MS Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1056/NEJMra050100", "article-title": "Adherence to medication", "volume": "353", "author": "Osterberg", "year": "2005", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1258/0956462011916875", "article-title": "Treatment-related empowerment: preliminary evaluation of a new measure in patients with advanced HIV disease", "volume": "12", "author": "Webb", "year": "2001", "journal-title": "Int J STD AIDS"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1001/archinte.160.14.2101", "article-title": "Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence", "volume": "160", "author": "DiMatteo", "year": "2000", "journal-title": "Arch Intern Med"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1200/JCO.1997.15.1.110", "article-title": "Patient preferences for oral versus intravenous palliative chemotherapy", "volume": "15", "author": "Liu", "year": "1997", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1093/annonc/mdj023", "article-title": "A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer", "volume": "17", "author": "Twelves", "year": "2006", "journal-title": "Ann Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1093/annonc/mdj044", "article-title": "Patients\u2019 preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer", "volume": "17", "author": "Fallowfield", "year": "2006", "journal-title": "Ann Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1517/17425247.4.1.63", "article-title": "First approved inhaled insulin therapy for diabetes mellitus", "volume": "4", "author": "Jani", "year": "2007", "journal-title": "Expert Opin Drug Deliv"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.2337/diacare.28.2.427", "article-title": "Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes", "volume": "28", "author": "Freemantle", "year": "2005", "journal-title": "Diabetes Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "2622", "DOI": "10.2337/diacare.27.11.2622", "article-title": "Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial", "volume": "27", "author": "Quattrin", "year": "2004", "journal-title": "Diabetes Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "2356", "DOI": "10.2337/diacare.27.10.2356", "article-title": "Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial", "volume": "27", "author": "Hollander", "year": "2004", "journal-title": "Diabetes Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "1318", "DOI": "10.2337/diacare.27.6.1318", "article-title": "Patient satisfaction and glycemic control after 1\u2003year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes", "volume": "27", "author": "Rosenstock", "year": "2004", "journal-title": "Diabetes Care"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB52|cit52", "doi-asserted-by": "crossref", "first-page": "1311", "DOI": "10.1016/S0149-2918(01)80110-7", "article-title": "Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus", "volume": "23", "author": "Dailey", "year": "2001", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S1474-4422(06)70327-1", "article-title": "Effects of oral glatiramer acetate on clinical and MRI-monitored disease activity in patients with relapsing multiple sclerosis: a multicentre, double-blind, randomised, placebo-controlled study", "volume": "5", "author": "Filippi", "year": "2006", "journal-title": "Lancet Neurol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "273", "DOI": "10.1016/S0162-3109(00)00191-0", "article-title": "Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases", "volume": "47", "author": "Herrmann", "year": "2000", "journal-title": "Immunopharmacology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB55|cit55", "first-page": "460", "article-title": "The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism", "volume": "272", "author": "Cherwinski", "year": "1995", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB56|cit56", "doi-asserted-by": "crossref", "first-page": "2730", "DOI": "10.1002/art.21255", "article-title": "Disruption of the interaction of T cells with antigen-presenting cells by the active leflunomide metabolite teriflunomide: involvement of impaired integrin activation and immunologic synapse formation", "volume": "52", "author": "Zeyda", "year": "2005", "journal-title": "Arthritis Rheum"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB57|cit57", "doi-asserted-by": "crossref", "first-page": "894", "DOI": "10.1212/01.wnl.0000203121.04509.31", "article-title": "A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses", "volume": "66", "author": "O'Connor", "year": "2006", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB58|cit58", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/j.jneuroim.2004.02.016", "article-title": "Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats", "volume": "156", "author": "Yang", "year": "2004", "journal-title": "J Neuroimmunol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB59|cit59", "doi-asserted-by": "crossref", "first-page": "987", "DOI": "10.1212/01.WNL.0000154520.48391.69", "article-title": "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS", "volume": "64", "author": "Polman", "year": "2005", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB60|cit60", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1177/135245850000600208", "article-title": "Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials", "volume": "6", "author": "Tan", "year": "2000", "journal-title": "Mult Scler"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB61|cit61", "author": "Mullershausen", "year": "2007", "article-title": "Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors", "journal-title": "J Neurochem", "DOI": "10.1111/j.1471-4159.2007.04629.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB62|cit62", "doi-asserted-by": "crossref", "first-page": "1077", "DOI": "10.1182/blood-2006-03-011437", "article-title": "The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors", "volume": "109", "author": "Payne", "year": "2007", "journal-title": "Blood"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB63|cit63", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.1016/j.jns.2004.04.025", "article-title": "New immunosuppressants with potential implication in multiple sclerosis", "volume": "223", "author": "Gonsette", "year": "2004", "journal-title": "J Neurol Sci"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB64|cit64", "first-page": "578", "article-title": "New immunosuppressive drugs for prevention and treatment of rejection in renal transplant", "volume": "19", "author": "Segoloni", "year": "2006", "journal-title": "J Nephrol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB65|cit65", "doi-asserted-by": "crossref", "first-page": "1124", "DOI": "10.1056/NEJMoa052643", "article-title": "Oral fingolimod (FTY720) for relapsing multiple sclerosis", "volume": "355", "author": "Kappos", "year": "2006", "journal-title": "N Engl J Med"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB66|cit66", "author": "Kappos", "year": "2006", "volume-title": "BG00012, a Novel Oral Fumarate, is Effective in Patients with Relapsing-Remitting Multiple Sclerosis"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB67|cit67", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1159/000017903", "article-title": "Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis", "volume": "196", "author": "Hoxtermann", "year": "1998", "journal-title": "Dermatology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB68|cit68", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1046/j.1365-2133.1999.03034.x", "article-title": "Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference", "volume": "141", "author": "Mrowietz", "year": "1999", "journal-title": "Br J Dermatol"}, {"issue": "Suppl. 2", "key": "10.1111/j.1742-1241.2007.01561..x-BIB69|cit69", "doi-asserted-by": "crossref", "first-page": "14593", "DOI": "10.1073/pnas.0404887101", "article-title": "Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications", "volume": "101", "author": "Arnon", "year": "2004", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB70|cit70", "doi-asserted-by": "crossref", "first-page": "1716", "DOI": "10.1073/pnas.93.4.1716", "article-title": "The treatment of chronic progressive multiple sclerosis with cladribine", "volume": "93", "author": "Beutler", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB71|cit71", "doi-asserted-by": "crossref", "first-page": "2232", "DOI": "10.1073/pnas.81.7.2232", "article-title": "Antileukemic and immunosuppressive activity of 2-chloro-2\u2032-deoxyadenosine", "volume": "81", "author": "Carson", "year": "1984", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB72|cit72", "first-page": "587", "article-title": "2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma", "volume": "80", "author": "Saven", "year": "1992", "journal-title": "Blood"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB73|cit73", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1200/JCO.1995.13.4.989", "article-title": "Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia", "volume": "13", "author": "Juliusson", "year": "1995", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB74|cit74", "first-page": "1918", "article-title": "Long-term follow-up of patients with hairy cell leukemia after cladribine treatment", "volume": "92", "author": "Saven", "year": "1998", "journal-title": "Blood"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB75|cit75", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1532/IJH97.04077", "article-title": "Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study", "volume": "80", "author": "Ogura", "year": "2004", "journal-title": "Int J Hematol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB76|cit76", "doi-asserted-by": "crossref", "first-page": "2804", "DOI": "10.1200/JCO.2001.19.11.2804", "article-title": "Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases", "volume": "19", "author": "Krance", "year": "2001", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB77|cit77", "doi-asserted-by": "crossref", "first-page": "2694", "DOI": "10.1200/JCO.1994.12.12.2694", "article-title": "Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine", "volume": "12", "author": "Dimopoulos", "year": "1994", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB78|cit78", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.2165/00003088-199732020-00003", "article-title": "The clinical pharmacokinetics of cladribine", "volume": "32", "author": "Liliemark", "year": "1997", "journal-title": "Clin Pharmacokinet"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB79|cit79", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1007/s00277-002-0554-4", "article-title": "Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine", "volume": "81", "author": "Valencak", "year": "2002", "journal-title": "Ann Hematol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB80|cit80", "doi-asserted-by": "crossref", "first-page": "376", "DOI": "10.3109/03009749709065702", "article-title": "The safety profile of low-dose cladribine in refractory rheumatoid arthritis. A pilot trial", "volume": "26", "author": "Schirmer", "year": "1997", "journal-title": "Scand J Rheumatol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB81|cit81", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1002/1529-0131(199802)41:2<335::AID-ART18>3.0.CO;2-O", "article-title": "A pilot study of 2-chloro-2\u2032-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis", "volume": "41", "author": "Davis", "year": "1998", "journal-title": "Arthritis Rheum"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB82|cit82", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1097/00004836-200012000-00005", "article-title": "An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis", "volume": "31", "author": "Duchini", "year": "2000", "journal-title": "J Clin Gastroenterol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB83|cit83", "first-page": "987", "article-title": "2-Chlorodeoxyadenosine as treatment of severe acute graft-versus-host disease", "volume": "84", "author": "Pless", "year": "1994", "journal-title": "Blood"}, {"issue": "Suppl. 2", "key": "10.1111/j.1742-1241.2007.01561..x-BIB84|cit84", "first-page": "S67", "article-title": "Pharmacology of purine nucleoside analogues", "volume": "38", "author": "Plunkett", "year": "1996", "journal-title": "Hematol Cell Ther"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB85|cit85", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1016/0140-6736(92)92826-2", "article-title": "Cladribine (2-chlorodeoxyadenosine)", "volume": "340", "author": "Beutler", "year": "1992", "journal-title": "Lancet"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB86|cit86", "doi-asserted-by": "crossref", "first-page": "1145", "DOI": "10.1212/WNL.54.5.1145", "article-title": "Cladribine and progressive MS: clinical and MRI outcomes of a multicenter controlled trial. Cladribine MRI Study Group", "volume": "54", "author": "Rice", "year": "2000", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB87|cit87", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1046/j.1525-1381.1999.09115.x", "article-title": "A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis", "volume": "111", "author": "Romine", "year": "1999", "journal-title": "Proc Assoc Am Physicians"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB88|cit88", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0140-6736(94)91046-4", "article-title": "Cladribine in treatment of chronic progressive multiple sclerosis", "volume": "344", "author": "Sipe", "year": "1994", "journal-title": "Lancet"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB89|cit89", "first-page": "45", "article-title": "Treatment of multiple sclerosis and other autoimmune diseases with cladribine", "volume": "33", "author": "Beutler", "year": "1996", "journal-title": "Semin Hematol"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB90|cit90", "first-page": "93", "article-title": "Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis", "volume": "7", "author": "Janiec", "year": "2001", "journal-title": "Med Sci Monit"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB91|cit91", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1586/14737175.5.6.721", "article-title": "Cladribine for multiple sclerosis: review and current status", "volume": "5", "author": "Sipe", "year": "2005", "journal-title": "Expert Rev Neurother"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB92|cit92", "doi-asserted-by": "crossref", "first-page": "636", "DOI": "10.1191/1352458504ms1114oa", "article-title": "A randomized open label study of pain medications (naproxen, acetaminophen and ibuprofen) for controlling side effects during initiation of IFN beta-1a therapy and during its ongoing use for relapsing-remitting multiple sclerosis", "volume": "10", "author": "Leuschen", "year": "2004", "journal-title": "Mult Scler"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB93|cit93", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1212/01.WNL.0000133206.44931.25", "article-title": "Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial", "volume": "63", "author": "Rio", "year": "2004", "journal-title": "Neurology"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB94|cit94", "doi-asserted-by": "crossref", "first-page": "735", "DOI": "10.1016/S0035-3787(06)75071-8", "article-title": "Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices", "volume": "162", "author": "Brochet", "year": "2006", "journal-title": "Rev Neurol (Paris)"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB95|cit95", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1177/147323000603400101", "article-title": "Safety and tolerability of a \u2019refrigeration-free\u2019 formulation of interferon beta-1b-results of a double-blind, multicentre, comparative study in patients with relapsing-remitting or secondary progressive multiple sclerosis", "volume": "34", "author": "Baum", "year": "2006", "journal-title": "J Int Med Res"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB96|cit96", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1016/S0149-2918(04)90053-7", "article-title": "A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis", "volume": "26", "author": "Phillips", "year": "2004", "journal-title": "Clin Ther"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB97|cit97", "first-page": "29", "article-title": "A Multiple Sclerosis (MS) Center Injection Training Program", "volume": "19", "author": "Pfohl", "year": "1997", "journal-title": "Axone"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB98|cit98", "doi-asserted-by": "crossref", "first-page": "350", "DOI": "10.1097/01376517-199612000-00002", "article-title": "Education and self-management of interferon beta-1b therapy for multiple sclerosis", "volume": "28", "author": "Keating", "year": "1996", "journal-title": "J Neurosci Nurs"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB99|cit99", "first-page": "96", "article-title": "[A wide support of patients with multiple sclerosis promotes success of long-term therapy]", "volume": "3", "author": "Sidorenko", "year": "2006", "journal-title": "Zh Nevrol Psikhiatr Im S S Korsakova"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB100|cit100", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1097/01376517-200402000-00003", "article-title": "Long-term treatment optimization in individuals with multiple sclerosis using disease-modifying therapies: a nursing approach", "volume": "36", "author": "Denis", "year": "2004", "journal-title": "J Neurosci Nurs"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB101|cit101", "unstructured": "Rieckmann P DMDs: Balancing Expectations and Adherence to Treatment European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2005"}, {"key": "10.1111/j.1742-1241.2007.01561..x-BIB102|cit102", "doi-asserted-by": "crossref", "first-page": "1088", "DOI": "10.1056/NEJMp068159", "article-title": "Fingolimod and sphingosine-1-phosphate-modifiers of lymphocyte migration", "volume": "355", "author": "Massberg", "year": "2006", "journal-title": "N Engl J Med"}], "container-title": ["International Journal of Clinical Practice"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1742-1241.2007.01561..x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 3]], "date-time": "2019-02-03T20:22:41Z", "timestamp": 1549225361000}, "score": 27.544258, "subtitle": ["Oral therapy for multiple sclerosis"], "issued": {"date-parts": [[2007, 9, 3]]}, "references-count": 102, "journal-issue": {"issue": "11"}, "URL": "http://dx.doi.org/10.1111/j.1742-1241.2007.01561..x", "relation": {"cites": []}, "ISSN": ["1368-5031"], "issn-type": [{"value": "1368-5031", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:30:07Z", "timestamp": 1575142207630}, "reference-count": 0, "publisher": "American Medical Association (AMA)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Neurol"], "published-print": {"date-parts": [[2005, 4, 1]]}, "DOI": "10.1001/archneur.62.4.563", "type": "journal-article", "created": {"date-parts": [[2005, 4, 11]], "date-time": "2005-04-11T21:25:50Z", "timestamp": 1113254750000}, "page": "563", "source": "Crossref", "is-referenced-by-count": 60, "title": ["Interferon Beta Promotes Nerve Growth Factor Secretion Early in the Course of Multiple Sclerosis"], "prefix": "10.1001", "volume": "62", "author": [{"given": "Katarzyna", "family": "Biernacki", "sequence": "first", "affiliation": []}, {"given": "Jack P.", "family": "Antel", "sequence": "additional", "affiliation": []}, {"given": "Manon", "family": "Blain", "sequence": "additional", "affiliation": []}, {"given": "Sridar", "family": "Narayanan", "sequence": "additional", "affiliation": []}, {"given": "Douglas L.", "family": "Arnold", "sequence": "additional", "affiliation": []}, {"given": "Alexandre", "family": "Prat", "sequence": "additional", "affiliation": []}], "member": "10", "container-title": ["Archives of Neurology"], "language": "en", "link": [{"URL": "http://jamanetwork.com/journals/jamaneurology/fullarticle/788205", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 17]], "date-time": "2016-12-17T04:32:46Z", "timestamp": 1481949166000}, "score": 27.499672, "issued": {"date-parts": [[2005, 4, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 4, 1]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1001/archneur.62.4.563", "ISSN": ["0003-9942"], "issn-type": [{"value": "0003-9942", "type": "print"}], "subject": ["Arts and Humanities (miscellaneous)", "Clinical Neurology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T01:09:19Z", "timestamp": 1574471359484}, "reference-count": 65, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 4, 25]], "date-time": "2012-04-25T00:00:00Z", "timestamp": 1335312000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Neurochem Res"], "published-print": {"date-parts": [[2012, 8]]}, "DOI": "10.1007/s11064-012-0779-0", "type": "journal-article", "created": {"date-parts": [[2012, 4, 24]], "date-time": "2012-04-24T04:22:14Z", "timestamp": 1335241334000}, "page": "1697-1706", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Inhibition of Nuclear Factor Erythroid 2-Related Factor 2 Exacerbates HIV-1 gp120-Induced Oxidative and Inflammatory Response: Role in HIV Associated Neurocognitive Disorder"], "prefix": "10.1007", "volume": "37", "author": [{"given": "Pichili Vijaya Bhaskar", "family": "Reddy", "sequence": "first", "affiliation": []}, {"given": "Marisela", "family": "Agudelo", "sequence": "additional", "affiliation": []}, {"given": "Venkata S. R.", "family": "Atluri", "sequence": "additional", "affiliation": []}, {"given": "Madhavan P.", "family": "Nair", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 4, 25]]}, "reference": [{"key": "779_CR1", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1038/nrn2040", "volume": "8", "author": "R Ellis", "year": "2007", "unstructured": "Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33\u201344", "journal-title": "Nat Rev Neurosci"}, {"key": "779_CR2", "doi-asserted-by": "crossref", "first-page": "152", "DOI": "10.1007/s11065-009-9102-5", "volume": "19", "author": "SP Woods", "year": "2009", "unstructured": "Woods SP, Moore DJ, Weber E, Grant I (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 19:152\u2013168", "journal-title": "Neuropsychol Rev"}, {"key": "779_CR3", "doi-asserted-by": "crossref", "first-page": "1367", "DOI": "10.1097/QAD.0b013e3283391d56", "volume": "24", "author": "JC McArthur", "year": "2010", "unstructured": "McArthur JC, Brew BJ (2010) HIV-associated neurocognitive disorders: is there a hidden epidemic? Aids 24:1367\u20131370", "journal-title": "Aids"}, {"key": "779_CR4", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1016/S0301-0082(97)00053-1", "volume": "54", "author": "A Nath", "year": "1998", "unstructured": "Nath A, Geiger J (1998) Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms. Prog Neurobiol 54:19\u201333", "journal-title": "Prog Neurobiol"}, {"key": "779_CR5", "doi-asserted-by": "crossref", "first-page": "e13427", "DOI": "10.1371/journal.pone.0013427", "volume": "5", "author": "Y Yang", "year": "2010", "unstructured": "Yang Y, Yao H, Lu Y, Wang C, Buch S (2010) Cocaine potentiates astrocyte toxicity mediated by human immunodeficiency virus (HIV-1) protein gp120. PLoS ONE 5:e13427", "journal-title": "PLoS ONE"}, {"key": "779_CR6", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/S0022-510X(02)00207-1", "volume": "202", "author": "A Minagar", "year": "2002", "unstructured": "Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci 202:13\u201323", "journal-title": "J Neurol Sci"}, {"key": "779_CR7", "doi-asserted-by": "crossref", "first-page": "745", "DOI": "10.1002/ana.1011", "volume": "49", "author": "KA Thompson", "year": "2001", "unstructured": "Thompson KA, McArthur JC, Wesselingh SL (2001) Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann Neurol 49:745\u2013752", "journal-title": "Ann Neurol"}, {"key": "779_CR8", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/0166-2236(92)90013-X", "volume": "15", "author": "SA Lipton", "year": "1992", "unstructured": "Lipton SA (1992) Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci 15:75\u201379", "journal-title": "Trends Neurosci"}, {"key": "779_CR9", "doi-asserted-by": "crossref", "first-page": "1353", "DOI": "10.1111/j.1460-9568.1995.tb01126.x", "volume": "7", "author": "H Ushijima", "year": "1995", "unstructured": "Ushijima H, Nishio O, Klocking R, Perovic S, Muller WE (1995) Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur J Neurosci 7:1353\u20131359", "journal-title": "Eur J Neurosci"}, {"key": "779_CR10", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1006/bbrc.1997.6131", "volume": "231", "author": "SE Ilyin", "year": "1997", "unstructured": "Ilyin SE, Plata-Salaman CR (1997) HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: implications to cytokine feedback systems. Biochem Biophys Res Commun 231:514\u2013518", "journal-title": "Biochem Biophys Res Commun"}, {"key": "779_CR11", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1016/S0304-3940(01)01786-4", "volume": "305", "author": "MY Aksenov", "year": "2001", "unstructured": "Aksenov MY, Hasselrot U, Bansal AK, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM (2001) Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci Lett 305:5\u20138", "journal-title": "Neurosci Lett"}, {"key": "779_CR12", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/S0006-8993(03)03194-9", "volume": "987", "author": "MY Aksenov", "year": "2003", "unstructured": "Aksenov MY, Hasselrot U, Wu G, Nath A, Anderson C, Mactutus CF, Booze RM (2003) Temporal relationships between HIV-1 Tat-induced neuronal degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein oxidation in the rat striatum. Brain Res 987:1\u20139", "journal-title": "Brain Res"}, {"key": "779_CR13", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1016/S0006-8993(00)02725-6", "volume": "879", "author": "AK Bansal", "year": "2000", "unstructured": "Bansal AK, Mactutus CF, Nath A, Maragos W, Hauser KF, Booze RM (2000) Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum. Brain Res 879:42\u201349", "journal-title": "Brain Res"}, {"key": "779_CR14", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1016/j.jneuroim.2004.08.037", "volume": "157", "author": "N Sacktor", "year": "2004", "unstructured": "Sacktor N, Haughey N, Cutler R, Tamara A, Turchan J, Pardo C, Vargas D, Nath A (2004) Novel markers of oxidative stress in actively progressive HIV dementia. J Neuroimmunol 157:176\u2013184", "journal-title": "J Neuroimmunol"}, {"key": "779_CR15", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1016/S0026-0495(00)80077-3", "volume": "49", "author": "DJ Betteridge", "year": "2000", "unstructured": "Betteridge DJ (2000) What is oxidative stress? Metabolism 49:3\u20138", "journal-title": "Metabolism"}, {"key": "779_CR16", "doi-asserted-by": "crossref", "first-page": "7264", "DOI": "10.4049/jimmunol.0804248", "volume": "182", "author": "NM Reddy", "year": "2009", "unstructured": "Reddy NM, Kleeberger SR, Kensler TW, Yamamoto M, Hassoun PM, Reddy SP (2009) Disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice. J Immunol 182:7264\u20137271", "journal-title": "J Immunol"}, {"key": "779_CR17", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1016/j.expneurol.2009.11.004", "volume": "221", "author": "JP Louboutin", "year": "2010", "unstructured": "Louboutin JP, Reyes BA, Agrawal L, Van Bockstaele EJ, Strayer DS (2010) HIV-1 gp120-induced neuroinflammation: relationship to neuron loss and protection by rSV40-delivered antioxidant enzymes. Exp Neurol 221:231\u2013245", "journal-title": "Exp Neurol"}, {"key": "779_CR18", "doi-asserted-by": "crossref", "first-page": "1298", "DOI": "10.1111/j.1471-4159.2008.05479.x", "volume": "106", "author": "PT Ronaldson", "year": "2008", "unstructured": "Ronaldson PT, Bendayan R (2008) HIV-1 viral envelope glycoprotein gp120 produces oxidative stress and regulates the functional expression of multidrug resistance protein-1 (Mrp1) in glial cells. J Neurochem 106:1298\u20131313", "journal-title": "J Neurochem"}, {"key": "779_CR19", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.1093/aob/mcf118", "volume": "91", "author": "O Blokhina", "year": "2003", "unstructured": "Blokhina O, Virolainen E, Fagerstedt KV (2003) Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot 91:179\u2013194", "journal-title": "Ann Bot"}, {"issue": "Suppl 2", "key": "779_CR20", "doi-asserted-by": "crossref", "first-page": "S193", "DOI": "10.1086/344528", "volume": "186", "author": "A Nath", "year": "2002", "unstructured": "Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193\u2013S198", "journal-title": "J Infect Dis"}, {"key": "779_CR21", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1016/S0197-0186(99)00126-6", "volume": "36", "author": "CB Pocernich", "year": "2000", "unstructured": "Pocernich CB, La Fontaine M, Butterfield DA (2000) In vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain. Neurochem Int 36:185\u2013191", "journal-title": "Neurochem Int"}, {"key": "779_CR22", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1016/j.molbrainres.2004.10.024", "volume": "133", "author": "CB Pocernich", "year": "2005", "unstructured": "Pocernich CB, Poon HF, Boyd-Kimball D, Lynn BC, Nath A, Klein JB, Butterfield DA (2005) Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Res Mol Brain Res 133:299\u2013306", "journal-title": "Brain Res Mol Brain Res"}, {"key": "779_CR23", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1016/S0306-4522(01)00332-3", "volume": "107", "author": "B Viviani", "year": "2001", "unstructured": "Viviani B, Corsini E, Binaglia M, Galli CL, Marinovich M (2001) Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience 107:51\u201358", "journal-title": "Neuroscience"}, {"key": "779_CR24", "doi-asserted-by": "crossref", "first-page": "13512", "DOI": "10.1074/jbc.M209381200", "volume": "278", "author": "A Chauhan", "year": "2003", "unstructured": "Chauhan A, Turchan J, Pocernich C, Bruce-Keller A, Roth S, Butterfield DA, Major EO, Nath A (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J Biol Chem 278:13512\u201313519", "journal-title": "J Biol Chem"}, {"issue": "Suppl 1", "key": "779_CR25", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1038/sj.cdd.4401577", "volume": "12", "author": "MP Mattson", "year": "2005", "unstructured": "Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 12(Suppl 1):893\u2013904", "journal-title": "Cell Death Differ"}, {"key": "779_CR26", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1212/01.WNL.0000042048.85204.3D", "volume": "60", "author": "J Turchan", "year": "2003", "unstructured": "Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J et al (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60:307\u2013314", "journal-title": "Neurology"}, {"key": "779_CR27", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1042/bj20031123", "volume": "377", "author": "Q Ma", "year": "2004", "unstructured": "Ma Q, Kinneer K, Bi Y, Chan JY, Kan YW (2004) Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap \u2018n\u2019 collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J 377:205\u2013213", "journal-title": "Biochem J"}, {"key": "779_CR28", "doi-asserted-by": "crossref", "first-page": "549", "DOI": "10.1016/j.molmed.2004.09.003", "volume": "10", "author": "H Motohashi", "year": "2004", "unstructured": "Motohashi H, Yamamoto M (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med 10:549\u2013557", "journal-title": "Trends Mol Med"}, {"key": "779_CR29", "doi-asserted-by": "crossref", "first-page": "32485", "DOI": "10.1074/jbc.M503074200", "volume": "280", "author": "T Nguyen", "year": "2005", "unstructured": "Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB (2005) Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem 280:32485\u201332492", "journal-title": "J Biol Chem"}, {"key": "779_CR30", "doi-asserted-by": "crossref", "first-page": "4125", "DOI": "10.1113/jphysiol.2011.210294", "volume": "589", "author": "A Alfieri", "year": "2011", "unstructured": "Alfieri A, Srivastava S, Siow RC, Modo M, Fraser PA, Mann GE (2011) Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J Physiol 589:4125\u20134136", "journal-title": "J Physiol"}, {"key": "779_CR31", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.1002/jnr.22577", "volume": "89", "author": "G Chen", "year": "2011", "unstructured": "Chen G, Fang Q, Zhang J, Zhou D, Wang Z (2011) Role of the Nrf2-ARE pathway in early brain injury after experimental subarachnoid hemorrhage. J Neurosci Res 89:515\u2013523", "journal-title": "J Neurosci Res"}, {"key": "779_CR32", "unstructured": "Guerrero-Beltran CE, Calderon-Oliver M, Pedraza-Chaverri J, Chirino YI (2010) Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol. doi: 10.1016/j.etp.2010.11.005", "DOI": "10.1016/j.etp.2010.11.005", "doi-asserted-by": "crossref"}, {"key": "779_CR33", "doi-asserted-by": "crossref", "first-page": "174", "DOI": "10.1016/j.brainres.2009.06.007", "volume": "1286", "author": "X Kuang", "year": "2009", "unstructured": "Kuang X, Scofield VL, Yan M, Stoica G, Liu N, Wong PK (2009) Attenuation of oxidative stress, inflammation and apoptosis by minocycline prevents retrovirus-induced neurodegeneration in mice. Brain Res 1286:174\u2013184", "journal-title": "Brain Res"}, {"key": "779_CR34", "doi-asserted-by": "crossref", "first-page": "588", "DOI": "10.1002/glia.20947", "volume": "58", "author": "AI Rojo", "year": "2010", "unstructured": "Rojo AI, Innamorato NG, Martin-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A (2010) Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease. Glia 58:588\u2013598", "journal-title": "Glia"}, {"key": "779_CR35", "doi-asserted-by": "crossref", "first-page": "1659", "DOI": "10.1002/jnr.21975", "volume": "87", "author": "A Siebert", "year": "2009", "unstructured": "Siebert A, Desai V, Chandrasekaran K, Fiskum G, Jafri MS (2009) Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res 87:1659\u20131669", "journal-title": "J Neurosci Res"}, {"key": "779_CR36", "unstructured": "Reddy PV, Gandhi N, Samikkannu T, Saiyed Z, Agudelo M, Yndart A, Khatavkar P, Nair MP (2011) HIV-1 gp120 induces antioxidant response element-mediated expression in primary astrocytes: Role in HIV associated neurocognitive disorder. Neurochem Int. doi: 10.1016/j.neuint.2011.06.011", "DOI": "10.1016/j.neuint.2011.06.011", "doi-asserted-by": "crossref"}, {"key": "779_CR37", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/j.freeradbiomed.2009.04.028", "volume": "47", "author": "HS Zhang", "year": "2009", "unstructured": "Zhang HS, Li HY, Zhou Y, Wu MR, Zhou HS (2009) Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. Free Radic Biol Med 47:261\u2013268", "journal-title": "Free Radic Biol Med"}, {"key": "779_CR38", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1007/s11481-009-9155-5", "volume": "4", "author": "T Ikezu", "year": "2009", "unstructured": "Ikezu T (2009) The aging of human-immunodeficiency-virus-associated neurocognitive disorders. J Neuroimmune Pharmacol 4:161\u2013162", "journal-title": "J Neuroimmune Pharmacol"}, {"key": "779_CR39", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1038/sj.jcbfm.9600330", "volume": "27", "author": "GD Kanmogne", "year": "2007", "unstructured": "Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y (2007) HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27:123\u2013134", "journal-title": "J Cereb Blood Flow Metab"}, {"key": "779_CR40", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/s10571-004-1383-x", "volume": "25", "author": "M Toborek", "year": "2005", "unstructured": "Toborek M, Lee YW, Flora G, Pu H, Andras IE, Wylegala E, Hennig B, Nath A (2005) Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol 25:181\u2013199", "journal-title": "Cell Mol Neurobiol"}, {"key": "779_CR41", "doi-asserted-by": "crossref", "first-page": "411", "DOI": "10.1016/S0166-2236(00)01819-1", "volume": "24", "author": "V Mollace", "year": "2001", "unstructured": "Mollace V, Nottet HS, Clayette P, Turco MC, Muscoli C, Salvemini D, Perno CF (2001) Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci 24:411\u2013416", "journal-title": "Trends Neurosci"}, {"key": "779_CR42", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1046/j.1471-4159.2001.00568.x", "volume": "79", "author": "A Nicolini", "year": "2001", "unstructured": "Nicolini A, Ajmone-Cat MA, Bernardo A, Levi G, Minghetti L (2001) Human immunodeficiency virus type-1 Tat protein induces nuclear factor (NF)-kappaB activation and oxidative stress in microglial cultures by independent mechanisms. J Neurochem 79:713\u2013716", "journal-title": "J Neurochem"}, {"key": "779_CR43", "doi-asserted-by": "crossref", "first-page": "458", "DOI": "10.1002/jlb.65.4.458", "volume": "65", "author": "J Rappaport", "year": "1999", "unstructured": "Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein. Tat J Leukoc Biol 65:458\u2013465", "journal-title": "Tat J Leukoc Biol"}, {"key": "779_CR44", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1002/glia.20017", "volume": "47", "author": "J Park", "year": "2004", "unstructured": "Park J, Choi K, Jeong E, Kwon D, Benveniste EN, Choi C (2004) Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells. Glia 47:9\u201320", "journal-title": "Glia"}, {"key": "779_CR45", "doi-asserted-by": "crossref", "first-page": "576", "DOI": "10.1016/j.freeradbiomed.2010.12.019", "volume": "50", "author": "HY Song", "year": "2011", "unstructured": "Song HY, Ju SM, Seo WY, Goh AR, Lee JK, Bae YS, Choi SY, Park J (2011) Nox2-based NADPH oxidase mediates HIV-1 Tat-induced up-regulation of VCAM-1/ICAM-1 and subsequent monocyte adhesion in human astrocytes. Free Radic Biol Med 50:576\u2013584", "journal-title": "Free Radic Biol Med"}, {"key": "779_CR46", "doi-asserted-by": "crossref", "first-page": "3394", "DOI": "10.1523/JNEUROSCI.23-08-03394.2003", "volume": "23", "author": "AY Shih", "year": "2003", "unstructured": "Shih AY, Johnson DA, Wong G, Kraft AD, Jiang L, Erb H, Johnson JA, Murphy TH (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci 23:3394\u20133406", "journal-title": "J Neurosci"}, {"key": "779_CR47", "doi-asserted-by": "crossref", "first-page": "11926", "DOI": "10.1128/JVI.78.21.11926-11938.2004", "volume": "78", "author": "W Qiang", "year": "2004", "unstructured": "Qiang W, Cahill JM, Liu J, Kuang X, Liu N, Scofield VL, Voorhees JR, Reid AJ, Yan M, Lynn WS, Wong PK (2004) Activation of transcription factor Nrf-2 and its downstream targets in response to moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes. J Virol 78:11926\u201311938", "journal-title": "J Virol"}, {"key": "779_CR48", "doi-asserted-by": "crossref", "first-page": "9176", "DOI": "10.1523/JNEUROSCI.1632-05.2005", "volume": "25", "author": "AY Abramov", "year": "2005", "unstructured": "Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, Duchen MR (2005) Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci 25:9176\u20139184", "journal-title": "J Neurosci"}, {"key": "779_CR49", "doi-asserted-by": "crossref", "first-page": "37412", "DOI": "10.1074/jbc.M704481200", "volume": "282", "author": "RF Wu", "year": "2007", "unstructured": "Wu RF, Ma Z, Myers DP, Terada LS (2007) HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases. J Biol Chem 282:37412\u201337419", "journal-title": "J Biol Chem"}, {"key": "779_CR50", "first-page": "611", "volume": "58", "author": "R Williams", "year": "2010", "unstructured": "Williams R, Yao H, Peng F, Yang Y, Bethel-Brown C, Buch S (2010) Cooperative induction of CXCL10 involves NADPH oxidase: Implications for HIV dementia. Glia 58:611\u2013621", "journal-title": "Glia"}, {"key": "779_CR51", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1089/ars.2008.2097", "volume": "11", "author": "J Turchan-Cholewo", "year": "2009", "unstructured": "Turchan-Cholewo J, Dimayuga VM, Gupta S, Gorospe RM, Keller JN, Bruce-Keller AJ (2009) NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antioxid Redox Signal 11:193\u2013204", "journal-title": "Antioxid Redox Signal"}, {"key": "779_CR52", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.4049/jimmunol.0902315", "volume": "185", "author": "X Kong", "year": "2010", "unstructured": "Kong X, Thimmulappa R, Kombairaju P, Biswal S (2010) NADPH oxidase-dependent reactive oxygen species mediate amplified TLR4 signaling and sepsis-induced mortality in Nrf2-deficient mice. J Immunol 185:569\u2013577", "journal-title": "J Immunol"}, {"key": "779_CR53", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1186/1742-2094-7-96", "volume": "7", "author": "A Shah", "year": "2010", "unstructured": "Shah A, Kumar A (2010) HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-kappaB pathway and can be silenced by gp120-specific siRNA. J Neuroinflammation 7:96", "journal-title": "J Neuroinflammation"}, {"key": "779_CR54", "doi-asserted-by": "crossref", "first-page": "1866", "DOI": "10.1016/j.freeradbiomed.2007.03.022", "volume": "42", "author": "RN Saha", "year": "2007", "unstructured": "Saha RN, Pahan K (2007) Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: implications for HIV-associated dementia. Free Radic Biol Med 42:1866\u20131878", "journal-title": "Free Radic Biol Med"}, {"key": "779_CR55", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1002/glia.20801", "volume": "57", "author": "R Williams", "year": "2009", "unstructured": "Williams R, Dhillon NK, Hegde ST, Yao H, Peng F, Callen S, Chebloune Y, Davis RL, Buch SJ (2009) Proinflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes. Glia 57:734\u2013743", "journal-title": "Glia"}, {"key": "779_CR56", "doi-asserted-by": "crossref", "first-page": "984", "DOI": "10.1172/JCI25790", "volume": "116", "author": "RK Thimmulappa", "year": "2006", "unstructured": "Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S (2006) Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 116:984\u2013995", "journal-title": "J Clin Invest"}, {"key": "779_CR57", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1007/s12263-007-0063-0", "volume": "2", "author": "YJ Surh", "year": "2008", "unstructured": "Surh YJ, Na HK (2008) NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr 2:313\u2013317", "journal-title": "Genes Nutr"}, {"key": "779_CR58", "first-page": "238321", "volume": "2010", "author": "L Mao", "year": "2011", "unstructured": "Mao L, Wang H, Qiao L, Wang X (2011) Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-alpha, and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators Inflamm 2010:238321", "journal-title": "Mediators Inflamm"}, {"key": "779_CR59", "doi-asserted-by": "crossref", "first-page": "879", "DOI": "10.2174/1381612043452901", "volume": "10", "author": "XL Chen", "year": "2004", "unstructured": "Chen XL, Kunsch C (2004) Induction of cytoprotective genes through Nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10:879\u2013891", "journal-title": "Curr Pharm Des"}, {"key": "779_CR60", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1006/bbrc.1997.6943", "volume": "236", "author": "K Itoh", "year": "1997", "unstructured": "Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I et al (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236:313\u2013322", "journal-title": "Biochem Biophys Res Commun"}, {"key": "779_CR61", "doi-asserted-by": "crossref", "first-page": "983", "DOI": "10.1053/gast.2003.50152", "volume": "124", "author": "N Mori", "year": "2003", "unstructured": "Mori N, Sato H, Hayashibara T, Senba M, Geleziunas R, Wada A, Hirayama T, Yamamoto N (2003) Helicobacter pylori induces matrix metalloproteinase-9 through activation of nuclear factor kappaB. Gastroenterology 124:983\u2013992", "journal-title": "Gastroenterology"}, {"key": "779_CR62", "doi-asserted-by": "crossref", "first-page": "86", "DOI": "10.3858/emm.2009.41.2.011", "volume": "41", "author": "SM Ju", "year": "2009", "unstructured": "Ju SM, Song HY, Lee JA, Lee SJ, Choi SY, Park J (2009) Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp Mol Med 41:86\u201393", "journal-title": "Exp Mol Med"}, {"key": "779_CR63", "doi-asserted-by": "crossref", "first-page": "9926", "DOI": "10.1073/pnas.91.21.9926", "volume": "91", "author": "P Moi", "year": "1994", "unstructured": "Moi P, Chan K, Asunis I, Cao A, Kan YW (1994) Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 91:9926\u20139930", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "779_CR64", "doi-asserted-by": "crossref", "first-page": "854", "DOI": "10.1086/515342", "volume": "178", "author": "B Sporer", "year": "1998", "unstructured": "Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, Pfister HW (1998) Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 178:854\u2013857", "journal-title": "J Infect Dis"}, {"key": "779_CR65", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1016/S0014-5793(98)01034-5", "volume": "435", "author": "M Bond", "year": "1998", "unstructured": "Bond M, Fabunmi RP, Baker AH, Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435:29\u201334", "journal-title": "FEBS Lett"}], "container-title": ["Neurochemical Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s11064-012-0779-0.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s11064-012-0779-0/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s11064-012-0779-0", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 1]], "date-time": "2019-06-01T04:34:43Z", "timestamp": 1559363683000}, "score": 27.445757, "issued": {"date-parts": [[2012, 4, 25]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2012, 8]]}, "issue": "8"}, "alternative-id": ["779"], "URL": "http://dx.doi.org/10.1007/s11064-012-0779-0", "relation": {"cites": []}, "ISSN": ["0364-3190", "1573-6903"], "issn-type": [{"value": "0364-3190", "type": "print"}, {"value": "1573-6903", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T14:53:58Z", "timestamp": 1574693638773}, "reference-count": 83, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "5", "content-domain": {"domain": ["ahajournals.org"], "crossmark-restriction": true}, "short-container-title": ["JAHA"], "published-print": {"date-parts": [[2015, 5, 14]]}, "DOI": "10.1161/jaha.115.001986", "type": "journal-article", "created": {"date-parts": [[2015, 5, 15]], "date-time": "2015-05-15T02:20:24Z", "timestamp": 1431656424000}, "update-policy": "http://dx.doi.org/10.1161/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 19, "title": ["Hydrogen Sulfide Levels and Nuclear Factor\u2010Erythroid 2\u2010Related Factor 2 (NRF2) Activity Are Attenuated in the Setting of Critical Limb Ischemia (CLI)"], "prefix": "10.1161", "volume": "4", "author": [{"given": "Kazi N.", "family": "Islam", "sequence": "first", "affiliation": [{"name": "Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}]}, {"given": "David J.", "family": "Polhemus", "sequence": "additional", "affiliation": [{"name": "Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}]}, {"given": "Erminia", "family": "Donnarumma", "sequence": "additional", "affiliation": [{"name": "Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}]}, {"given": "Luke P.", "family": "Brewster", "sequence": "additional", "affiliation": [{"name": "Emory University School of Medicine, Atlanta, GA"}]}, {"given": "David J.", "family": "Lefer", "sequence": "additional", "affiliation": [{"name": "Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA"}]}], "member": "276", "reference": [{"key": "e_1_3_3_2_2", "DOI": "10.1016/j.ejvs.2006.11.008", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_3_2", "DOI": "10.1016/j.jvs.2010.10.094", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_4_2", "DOI": "10.1016/j.jvs.2006.12.037", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_5_2", "DOI": "10.1161/circresaha.109.199919", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_6_2", "first-page": "11", "article-title": "Epidemiology of critical limb ischaemia: North Italian data", "volume": "2", "author": "Catalano M", "year": "1993", "journal-title": "Eur J Med"}, {"key": "e_1_3_3_7_2", "DOI": "10.1111/j.1464-5491.2009.02698.x", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_8_2", "DOI": "10.1016/j.ejvs.2005.12.022", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_9_2", "DOI": "10.1177/1538574406297268", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_10_2", "DOI": "10.1177/000331979504601208", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_11_2", "DOI": "10.1016/0272-0590(89)90053-5", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_12_2", "DOI": "10.7326/0003-4819-85-6-756", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_13_2", "DOI": "10.1242/jeb.02376", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_14_2", "DOI": "10.1053/j.gastro.2006.02.033", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_15_2", "first-page": "4", "article-title": "Hydrogen sulfide (H2S)\u2014the third gas of interest for pharmacologists", "volume": "59", "author": "Lowicka E", "year": "2007", "journal-title": "Pharmacol Rep"}, {"key": "e_1_3_3_16_2", "DOI": "10.2174/157016106775203144", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_17_2", "DOI": "10.1093/emboj/20.21.6008", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_18_2", "DOI": "10.1055/s-0028-1088299", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_19_2", "DOI": "10.1007/s00726-010-0510-x", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_20_2", "DOI": "10.1089/ars.2011.4345", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_21_2", "DOI": "10.1152/japplphysiol.00793.2005", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_22_2", "DOI": "10.1089/ars.2011.4401", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_23_2", "DOI": "10.1016/j.neuint.2007.05.016", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_24_2", "DOI": "10.1007/s10545-009-9006-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_25_2", "DOI": "10.1111/j.1582-4934.2009.00645.x", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_26_2", "DOI": "10.1089/ars.2012.4612", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_27_2", "DOI": "10.1016/j.ab.2005.03.024", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_28_2", "DOI": "10.1038/nrd2425", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_29_2", "DOI": "10.1152/ajpheart.00377.2008", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_30_2", "DOI": "10.1016/j.yjmcc.2005.10.003", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_31_2", "DOI": "10.1021/tx2005234", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_32_2", "DOI": "10.1152/ajpregu.90566.2008", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_33_2", "DOI": "10.1074/jbc.R110.128363", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_34_2", "DOI": "10.1042/CS20100462", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_35_2", "DOI": "10.1146/annurev-pharmtox-010510-100505", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_36_2", "DOI": "10.1586/ecp.10.130", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_37_2", "DOI": "10.1016/j.bbabio.2009.03.019", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_38_2", "DOI": "10.1152/ajpregu.00045.2011", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_39_2", "DOI": "10.1016/j.jchromb.2009.05.026", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_40_2", "DOI": "10.1152/ajpregu.00025.2008", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_41_2", "DOI": "10.1016/j.ejcts.2008.03.017", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_42_2", "DOI": "10.1016/j.jss.2009.05.010", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_43_2", "DOI": "10.1007/s00395-005-0569-9", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_44_2", "DOI": "10.1089/ars.2006.8.661", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_45_2", "DOI": "10.1089/ars.2008.2282", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_46_2", "DOI": "10.1038/sj.bjp.0707540", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_47_2", "DOI": "10.1097/SHK.0b013e318180ff89", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_48_2", "DOI": "10.1016/j.jtcvs.2008.08.074", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_49_2", "DOI": "10.1016/j.cardiores.2007.05.026", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_50_2", "DOI": "10.1152/ajpheart.00088.2007", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_51_2", "DOI": "10.1291/hypres.31.1619", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_52_2", "DOI": "10.1161/atvbaha.108.179333", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_53_2", "DOI": "10.1096/fj.06-6270fje", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_54_2", "DOI": "10.1211/jpp.61.02.0010", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_55_2", "DOI": "10.1007/s00726-007-0011-8", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_56_2", "DOI": "10.1152/ajprenal.00145.2009", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_57_2", "DOI": "10.1089/ars.2008.2073", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_58_2", "DOI": "10.1016/j.bbrc.2006.10.058", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_59_2", "DOI": "10.1016/j.freeradbiomed.2008.11.018", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_60_2", "DOI": "10.1172/JCI21968", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_61_2", "DOI": "10.1111/j.1471-4159.2004.02617.x", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_62_2", "DOI": "10.1016/j.bbrc.2003.11.130", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_63_2", "DOI": "10.1161/01.atv.0000224324.52466.e6", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_64_2", "DOI": "10.1124/dmd.106.014340", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_65_2", "DOI": "10.1074/jbc.M111.324566", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_66_2", "DOI": "10.1016/S0891-5849(96)00493-5", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_67_2", "DOI": "10.1073/pnas.1321871111", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_68_2", "DOI": "10.1007/s00424-007-0321-4", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_69_2", "DOI": "10.1161/circulationaha.112.000855", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_70_2", "DOI": "10.1161/circheartfailure.113.000299", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_71_2", "DOI": "10.1161/circulationaha.108.778688", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_72_2", "DOI": "10.1016/j.niox.2011.06.001", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_73_2", "DOI": "10.1016/j.yjmcc.2008.10.007", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_74_2", "first-page": "1159", "article-title": "Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2\u2010deficient mice", "volume": "13", "author": "Yoh K", "year": "2008", "journal-title": "Genes Cells"}, {"key": "e_1_3_3_75_2", "DOI": "10.1155/2014/260429", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_76_2", "DOI": "10.1073/pnas.0307301101", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_77_2", "DOI": "10.1016/S0140-6736(09)60503-1", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_78_2", "DOI": "10.1056/NEJMoa060989", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_79_2", "DOI": "10.1093/eurheartj/ehn534", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_80_2", "DOI": "10.1056/NEJMoa0801317", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_81_2", "first-page": "1462", "article-title": "2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)", "volume": "28", "author": "Mancia G", "year": "2007", "journal-title": "Eur Heart J"}, {"key": "e_1_3_3_82_2", "DOI": "10.1001/archinte.1991.00400090063012", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_83_2", "DOI": "10.1056/NEJM200001203420301", "doi-asserted-by": "publisher"}, {"key": "e_1_3_3_84_2", "first-page": "260", "article-title": "Managing painful neuropathy in diabetes", "volume": "118", "author": "Jude EB", "year": "2008", "journal-title": "Pol Arch Med Wewn"}], "container-title": ["Journal of the American Heart Association"], "language": "en", "deposited": {"date-parts": [[2019, 9, 23]], "date-time": "2019-09-23T08:23:08Z", "timestamp": 1569226988000}, "score": 27.445757, "issued": {"date-parts": [[2015, 5, 14]]}, "references-count": 83, "journal-issue": {"published-print": {"date-parts": [[2015, 5, 14]]}, "issue": "5"}, "alternative-id": ["10.1161/JAHA.115.001986"], "URL": "http://dx.doi.org/10.1161/jaha.115.001986", "relation": {"cites": []}, "ISSN": ["2047-9980", "2047-9980"], "issn-type": [{"value": "2047-9980", "type": "print"}, {"value": "2047-9980", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:05:54Z", "timestamp": 1574730354087}, "reference-count": 0, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 23]], "date-time": "2015-09-23T00:00:00Z", "timestamp": 1442966400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions", "start": {"date-parts": [[2015, 9, 23]], "date-time": "2015-09-23T00:00:00Z", "timestamp": 1442966400000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Ophthalmol"], "published-print": {"date-parts": [[2015, 10]]}, "DOI": "10.1111/j.1755-3768.2015.0486", "type": "journal-article", "created": {"date-parts": [[2015, 9, 23]], "date-time": "2015-09-23T22:40:03Z", "timestamp": 1443048003000}, "page": "n/a-n/a", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Nuclear factor-erythroid 2-related factor-2 (Nrf2) and peroxisome proliferator-activated receptor\u03b3coactivator-1\u03b1(PGC-1\u03b1) regulates proteolysis in cornea"], "prefix": "10.1111", "volume": "93", "author": [{"given": "A.", "family": "Smedowski", "sequence": "first", "affiliation": [{"name": "Ophthalmology; University of Eastern Finland; Kuopio Finland"}, {"name": "Physiology; Medical University of Silesia; Katowice Poland"}, {"name": "Ophthalmology; Medical University of Silesia; Katowice Poland"}]}, {"given": "J.J.", "family": "Paterno", "sequence": "additional", "affiliation": [{"name": "Ophthalmology; University of Eastern Finland; Kuopio Finland"}, {"name": "Ophthalmology; Kuopio University Hospital; Kuopio Finland"}]}, {"given": "M.", "family": "Amadio", "sequence": "additional", "affiliation": [{"name": "Department of Drug Sciences; University of Pavia; Pavia Italy"}]}, {"given": "A.L.", "family": "Levonen", "sequence": "additional", "affiliation": [{"name": "Department of Biotechnology and Molecular Medicine-A.I. Virtanen Institute for Molecular Sciences; University of Eastern Finland; Kuopio Finland"}]}, {"given": "P.", "family": "Tavi", "sequence": "additional", "affiliation": [{"name": "Department of Biotechnology and Molecular Medicine-A.I. Virtanen Institute for Molecular Sciences; University of Eastern Finland; Kuopio Finland"}]}, {"given": "K.", "family": "Kaarniranta", "sequence": "additional", "affiliation": [{"name": "Ophthalmology; University of Eastern Finland; Kuopio Finland"}, {"name": "Ophthalmology; Kuopio University Hospital; Kuopio Finland"}]}, {"given": "E.", "family": "Wylegala", "sequence": "additional", "affiliation": [{"name": "Ophthalmology; Medical University of Silesia; Katowice Poland"}]}], "member": "311", "published-online": {"date-parts": [[2015, 9, 23]]}, "container-title": ["Acta Ophthalmologica"], "language": "en", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1755-3768.2015.0486", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2015, 9, 23]], "date-time": "2015-09-23T22:43:20Z", "timestamp": 1443048200000}, "score": 27.445757, "issued": {"date-parts": [[2015, 9, 23]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1111/j.1755-3768.2015.0486", "archive": ["Portico"], "ISSN": ["1755-375X"], "issn-type": [{"value": "1755-375X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T02:35:44Z", "timestamp": 1574562944756}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1016/j.msard.2014.09.202", "type": "journal-article", "created": {"date-parts": [[2014, 11, 21]], "date-time": "2014-11-21T18:30:46Z", "timestamp": 1416594646000}, "page": "759-760", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Osteopontin and Oncostatin M increase significantly in Iranian relapsing-remitting multiple sclerosis patients"], "prefix": "10.1016", "volume": "3", "author": [{"given": "P.", "family": "Alikhani", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Alsahebfosoul", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Etemadifar", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Shajarian", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S221103481400306X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S221103481400306X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T14:54:55Z", "timestamp": 1538060095000}, "score": 27.31323, "issued": {"date-parts": [[2014, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 11]]}, "issue": "6"}, "alternative-id": ["S221103481400306X"], "URL": "http://dx.doi.org/10.1016/j.msard.2014.09.202", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T02:35:48Z", "timestamp": 1574562948192}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "6", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 11, 1]], "date-time": "2014-11-01T00:00:00Z", "timestamp": 1414800000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Multiple Sclerosis and Related Disorders"], "published-print": {"date-parts": [[2014, 11]]}, "DOI": "10.1016/j.msard.2014.09.210", "type": "journal-article", "created": {"date-parts": [[2014, 11, 21]], "date-time": "2014-11-21T18:31:29Z", "timestamp": 1416594689000}, "page": "763", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Sleep quality among patients with multiple sclerosis in West Azerbaijan"], "prefix": "10.1016", "volume": "3", "author": [{"given": "S.", "family": "Taghavifar", "sequence": "first", "affiliation": []}, {"given": "N.M.", "family": "Zaie", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Mosarrezaii", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Ghasemzadeh", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Fazelkia", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Multiple Sclerosis and Related Disorders"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2211034814003149?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2211034814003149?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 27]], "date-time": "2018-09-27T14:54:36Z", "timestamp": 1538060076000}, "score": 27.31323, "issued": {"date-parts": [[2014, 11]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 11]]}, "issue": "6"}, "alternative-id": ["S2211034814003149"], "URL": "http://dx.doi.org/10.1016/j.msard.2014.09.210", "ISSN": ["2211-0348"], "issn-type": [{"value": "2211-0348", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}